ACHN Forecast and Technical Stock AnalysisSell candidate since 2019-06-20 Loss -17.36%
Achillion Pharmaceuticals fell by -1.65% in the last day ( Friday, 19th Jul 2019 ) from $2.42 to $2.38 During day the stock fluctuated 3.36% from a day low at $2.38 to a day high of $2.46. The price has fallen in 7 of the last 10 days and is down by -12.18% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -9 982 shares and in total 517 072 shares bought and sold for approximately $1.23 million.
- 30 day high of the ACHN stock price was $3.06 and low was $2.35.
- 90 day high was $3.25 and low was $2.35.
- 52 week high for the Achillion Pharmaceuticals - $3.98 and low - $1.29.
Achillion Pharmaceuticals lies in the lower of a wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.33 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.97% during the next 3 months and, with 90% probability hold a price between $1.96 and $2.37 at the end of this period.
There are few to none technical positive signals at the moment. Achillion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.45 and $2.72. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday July 03, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 30 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 3.36%. For the last week the stock has had a daily average volatility of 3.35%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.35 %Average volatility
Very Low Low Medium High Very High
Achillion Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
|ACHN $2.38 ($-0.04 -1.65%)|
ACHN is down $0.04 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACHN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACHN analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now